These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28107598)

  • 21. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco cessation interventions for young people.
    Grimshaw GM; Stanton A
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003289. PubMed ID: 17054164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
    Heinzerling KG; Swanson AN; Hall TM; Yi Y; Wu Y; Shoptaw SJ
    Addiction; 2014 Nov; 109(11):1878-86. PubMed ID: 24894963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatments for methamphetamine addiction: current status and future directions.
    Ballester J; Valentine G; Sofuoglu M
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence.
    Brown ES; Gabrielson B
    J Affect Disord; 2012 Dec; 143(1-3):257-60. PubMed ID: 22974472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
    Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
    Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study.
    McKetin R; Kothe A; Baker AL; Lee NK; Ross J; Lubman DI
    Drug Alcohol Rev; 2018 Jan; 37(1):70-78. PubMed ID: 28421682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.
    Brecht ML; Herbeck D
    Drug Alcohol Depend; 2014 Jun; 139():18-25. PubMed ID: 24685563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
    Kotajima-Murakami H; Takano A; Ogai Y; Tsukamoto S; Murakami M; Funada D; Tanibuchi Y; Tachimori H; Maruo K; Sasaki T; Matsumoto T; Ikeda K
    Neuropsychopharmacol Rep; 2019 Jun; 39(2):90-99. PubMed ID: 30756527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).
    Brecht ML; Greenwell L; Anglin MD
    J Subst Abuse Treat; 2005 Dec; 29(4):295-306. PubMed ID: 16311182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.
    Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W
    J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
    Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
    Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibudilast may improve attention during early abstinence from methamphetamine.
    Birath JB; Briones M; Amaya S; Shoptaw S; Swanson AN; Tsuang J; Furst B; Heinzerling K; Obermeit L; Maes L; McKay C; Wright MJ
    Drug Alcohol Depend; 2017 Sep; 178():386-390. PubMed ID: 28704767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of methamphetamine on traumatic injury complications and outcomes.
    Neeki MM; Dong F; Liang L; Toy J; Carrico B; Jabourian N; Sin A; Hussain F; Brown S; Safdari K; Borger R; Wong D
    Addict Sci Clin Pract; 2018 Mar; 13(1):11. PubMed ID: 29592800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
    Sigmon SC; Miller ME; Meyer AC; Saulsgiver K; Badger GJ; Heil SH; Higgins ST
    Addiction; 2016 May; 111(5):903-12. PubMed ID: 26638126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.